US Health Report Says Cluster of Drug-resistant Mpox Identified in 5 States

At least 18 cases of Clade II Mpox virus between October 6, 2023, and February 15, 2024, of those individuals who had never taken the treatment before, have been reported by US federal health officials, according to a CDC study. The research says these cases are resistant to Siga Technologies' antiviral tecovirimat, branded as TPOXX, in five states. Read on to know more.